Brief: Schott Pharma Q3 Revenues Up 1% YoY To EUR 256 Mln
12/08/2025 06:02
Aug 12 (Reuters) - SCHOTT PHARMA AG & CO KGAA 1SXP.DE: SCHOTT PHARMA AG & CO KGAA - Q3 2025 REVENUES UP 1% YOY TO EUR 256M; INCREASE OF 3% YOY AT CONSTANT CURRENCIES SCHOTT PHARMA AG & CO KGAA - Q3 2025 EBITDA MARGIN OF 32.4% AS REPORTED AND 31.7% AT CONSTANT CURRENCIES SCHOTT PHARMA AG & CO KGAA - EBITDA MARGIN FOR FY 2025 IS EXPECTED TO BE AROUND 28.0% SCHOTT PHARMA AG & CO KGAA - ORGANIC REVENUE GROWTH FOR FY 2025 IS EXPECTED TO BE AROUND 6.0% Source text: ID:nEQ7GBMhya Further company coverage: 1SXP.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))